For citations:
Shatalova N.A., Ostroumova O.D., Korotkova T.N., Vorozhko I.V., Klychnikova E.V., Ebzeeva E.Yu., Godkov M.A., Starodubova A.V., Mirzaev K.B., Sychev D.A. Relationship between renal damage marker levels and the presence of bleeding in patients with atrial fibrillation and chronic kidney disease receiving rivaroxaban. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2024;(1):45-55. (In Russ.) https://doi.org/10.37489/2588-0519-2024-1-45-55. EDN: NFMUDT